Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Showing 20 of 0 results

Not applicableStudy completedNCT04354610
What this trial is testing

Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection

Who this might be right for
COVID 19
Central Hospital, Nancy, France 73
Not applicableStudy completedNCT07261085
What this trial is testing

Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.

Who this might be right for
COVID-19
Pfizer 99,000
Not applicableStudy completedNCT04995289
What this trial is testing

Prone Position During ECMO in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hypoxaemic Patient

Who this might be right for
SARS CoV 2 InfectionHypoxemic Respiratory Failure
Mohammed VI University Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT04547140
What this trial is testing

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Grifols Therapeutics LLC 57
Testing effectiveness (Phase 2)Ended earlyNCT05659459
What this trial is testing

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2

Who this might be right for
COVID-19
Kinarus AG 17
Large-scale testing (Phase 3)UnknownNCT04703608
What this trial is testing

Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia

Who this might be right for
Covid-19
London School of Hygiene and Tropical Medicine 1,200
Early research (Phase 1)UnknownNCT04747574
What this trial is testing

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

Who this might be right for
SARS-CoV-2
Tel-Aviv Sourasky Medical Center 35
Not applicableStudy completedNCT04981249
What this trial is testing

Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection

Who this might be right for
Covid-19Chronic Disease
Corporacion Parc Tauli 14,286
Not applicableActive Not RecruitingNCT05467917
What this trial is testing

ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases

Who this might be right for
COVID-19HouseholdsSARS CoV 2 Infection
Columbia University 374
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984
What this trial is testing

Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Who this might be right for
COVID-19
Inmunova S.A. 243
Not applicableLooking for participantsNCT04582903
What this trial is testing

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Who this might be right for
COVID-19 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Large-scale testing (Phase 3)Study completedNCT04467840
What this trial is testing

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

Who this might be right for
COVID-19Lung Infection
RedHill Biopharma Limited 475
Large-scale testing (Phase 3)WithdrawnNCT04575064
What this trial is testing

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19
Professor Dr. Bernd Mühlbauer
Testing effectiveness (Phase 2)UnknownNCT04299152
What this trial is testing

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) Pneumonia
Throne Biotechnologies Inc. 20
Not applicableStudy completedNCT04490200
What this trial is testing

Effectiveness of a Novel Respirator With Chitosan Nanoparticles

Who this might be right for
Covid19SARS-CoV InfectionWorker-Patient Transmission, Healthcare
University of Brasilia 300
Testing effectiveness (Phase 2)Study completedNCT04710199
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Virus Diseases
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 44
Large-scale testing (Phase 3)Study completedNCT04510493
What this trial is testing

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Who this might be right for
Coronavirus InfectionDiabetes Mellitus, Type 2
University Hospital, Basel, Switzerland 116
Not applicableStudy completedNCT04583319
What this trial is testing

Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection

Who this might be right for
SARS-CoV
Firalis SA 300
Early research (Phase 1)Looking for participantsNCT07445971
What this trial is testing

A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.

Who this might be right for
COVID -19COVID-19 (Prevention)
ModeX Therapeutics, An OPKO Health Company 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation